What moved 3SMO.PA stock intraday today?

3SMO.PA stock rose to **EUR 632.53** (+**9.93%**) intraday, driven by sharp moves in the underlying and thin liquidity. The ETP’s leveraged inverse structure amplifies MRNA-driven swings, so small trades can push price quickly.

How does liquidity affect trading 3SMO.PA stock?

Liquidity is low: reported volume **3** vs average **29**, producing wide spreads and slippage risk. For 3SMO.PA stock, use limit orders, check order book depth and size positions conservatively to avoid execution surprises.

What is Meyka AI’s short-term forecast for 3SMO.PA stock?

Meyka AI's forecast model projects a near-term level of **EUR 450.00** (implied **-28.86%** from **EUR 632.53**) with a 3-month scenario at **EUR 380.00**. Forecasts are model-based projections and not guarantees.

Should investors hold 3SMO.PA stock long term?

3SMO.PA stock is a leveraged daily inverse ETP, not intended for long-term buy-and-hold. Meyka AI rates it **C+ (HOLD)** for active trading with tight risk controls. Long-term exposure can suffer from daily compounding and decay.

EU Stocks

3SMO.PA up 9.93% GraniteShares EURONEXT intraday 20 Mar 2026: watch volume

ByDanny Kontos March 20, 2026March 20, 2026

We see 3SMO.PA stock trading at EUR 632.53 intraday on EURONEXT, up 9.93% from yesterday as of this session. The GraniteShares 3x Short Moderna ETP recorded a day range of EUR 576.00–EUR 632.53 and a reported print volume of 3 shares versus an average volume of 29. Traders should note the jump in price with very thin liquidity — a signal-driven move rather than broad market participation. We cover the technicals, Meyka AI grade and near-term forecast to explain what the move means for short-term traders.